Purpose: The aim of this study was to evaluate and assess the correlation of CA19-9 and P57 expression with invasive front and grade of OSCC.
Introduction
Oral squamous cell carcinoma (OSCC) is one of the most widely occurring cancers worldwide. [1] It is the eighth most common cancer in males throughout the world, whereas it is not ranked among the top ten cancers in females. [1] [2] It is generally more common in developing countries, and its incidence and mortality rates are widely variable among different populations. [1, 3] Although many advances have been made in the field of oncology and surgical techniques, the mean incidence, and mortality rates have not changed significantly [4] and despite several therapeutic modalities including surgery, radiotherapy, and chemotherapy applied for three decades, the 5-year survival rate has only increased slightly in the past two decades. [5] Reducing the growing cancer burden depends on its early detection; [6] thus, early diagnosis of primary tumors is the key to improve treatment outcome.
Alterations in gene sequences, expression levels and protein structure or function have been associated with every type of cancer. Detecting cancer, determining prognosis, and monitoring disease progression or treatment response can be done based on these molecular markers. [7] CA19-9 is an isolated form of Lewis antigen. It is widely used for detecting pancreatic cancer in the clinical setting. [8] However, CA19-9 may be elevated in patients with gastrointestinal cancers [9] and nonmalignant gastrointestinal [10] or respiratory [11] [12] diseases. Its expression is limited to malignant and premalignant cells and it is rarely expressed in normal tissues or benign lesions. [13] P57 (KiP2) is a tumor suppressor gene. It is a positive regulator of cell proliferation, regulating proliferation through G1 phase by inhibiting cyclin dependent kinases. Its expression decreases in most malignancies [14] and it was shown that P57 (kip2) expression decreased in oral leukoplakia with moderate or severe dysplasia, and further decreased in oral SCC. [15] [16] OSCC has variable differentiation grades and invasion potential, ranging from a local invasion to a distant metastasis. The aim of this study was to assess the correlation of CA19-9 and P57 expression with invasive front and grade of OSCC. The proportional score (percentage of positively stained cells) (PS) was measured as described by Roh et al. [17] The cutoff point for the PS was 1% for CA19-9 [22] and 10% for P57. [15] Staining intensity in margins (margin intensity) and center of tumor (tumor intensity) was measured by a semi-quantitative scale for both markers from 0 (no staining) to 3 (strong staining). [18] Margin of the tumor can be defined as the margin of tumor invasion to healthy surrounded tissues. These ma- rker's expression were calculated by combining the intensity score (0-3) with the proportional score (0-4) to give a score within the range 0-12 for total score. [19] Statistical analysis was performed using SPSS version 11 software. The Kruskal Wallis test was used to compare biomarkers among the three grades. The Spearman's correlation test was applied to assess the correlation of marker and determinants of each marker.
Materials and Method
The Wilcoxon signed rank test was used to evaluate the expression of markers in tumor margins.
Results
Forty paraffin blocks from OSCC patients were included. Patients' age ranged from 34 to 85 years (mean 58.6±14.3 years). Nineteen patients were males and 21
were females. In terms of degree of differentiation, well-differentiated SCC was noted in twenty samples, moderate in fourteen and poorly differentiated SCC was noted in six samples. Most cases occurred in the tongue (32.5%) followed by keratinized (hard palate, gingiva) (30%) and non-keratinized oral mucosa (floor of the mouth, buccal and vestibular mucosa) (30%) and the lips (7.5%).
CA19-9
The frequency of tumor intensity scores (TI), margin intensity scores (MI), PS and TS in relation to tumor grades are shown in Table 1 -3. CA19-9 staining was low in all three grades. Statistical analysis showed no significant differences among the grades in TI, MI, PS, and TS. Significant correlations were observed between MI with TI (p= 0.000) and MI with PS (p=0.001). The Kruskal Wallis test showed no significant correlation between tumor grade and CA19-9 expression; however, there was a significant difference between TI and MI (p= 0.003). (Figure 2a) 
P57
The frequency tables for TI, MI, PS and TS in relation to tumor grades are shown in table 1-3. P57 staining was 
CA19-9 and P57 correlation
There was no significant correlation between CA19-9 and P57 expression.
Discussion
The aim of our study was to assess the correlation of CA19-9 and P57 with invasive front and grade of OSCC. We used immunohistochemical assays (Envision method) to evaluate the expression of markers.
Other studies have used the same method. [13, [15] [16] [17] [18] [19] [20] [21] [22] [23] Krimmel et al. [24] and Ren et al. [25] assessed the correlation of CA19-9 serum level and oral cancer. Another study measured the salivary level of this marker and reported increased level of CA19-9 in patients with premalignant and malignant oral tissues; however, it was not significant. [26] Moreover, 90% of the cases showed high and moderate and 10% presented low intensity of staining for CA19-9. This result and the measuring methods were similar to those in the study by Roh et al. [17] and Driessen et al.; [13] however in the study by Rajaganeshan et al., [19] number of patients with high expression of this marker was fewer than those with lower expression. Vermylen et al. [20] obtai- of cases showed high intensity of staining for CA19-9.
Vermylen et al. [20] reported strong staining in invasive fronts of 60% of invasive squamous epithelium.
In the current study, we used the method previously used by Tanaka et al. [27] to report the expression of markers. We selected the median score as the cutoff point and 80% of samples showed high expression of CA19-9 in tumor according to TS (median score= 5.5).
In the present study, 60% of well-differentiated and 50% of moderately differentiated SCC samples had rates. [19] Hedley et al. [18] concluded that CA19-9 is affected by tumor pH, since this marker has a higher expression in central parts with lower pH.
Tanaka et al. [17] showed low intensity. Proportional score for all the samples was higher than 10%. The PS for P57 was high in the studies by Ito et al. [21] and Fan et al., [16] although they had performed their studies on pancreatic adenocarcinoma and laryngeal SCC, respectively. In most of our samples, lymphocytes were stained; which was similar to the study by Ito et al. [21] and it was considered as internal positive control. It represents the stimulation of immune system against tumoral cells. In our study, samples with poor differentiation had the highest percentage of stained cells (98.3±1.6 %).
There were samples of well-differentiated tumors with high intensity of staining in the tumor and margins.
P57 is a tumor suppressor gene, which seems to have a high expression in well-differentiated tumors and it has no role in grading of tumor and invasive front of tumor.
In addition, studies of Fan et al. [15] [16] demonstrated P57 expression decreased with higher grades of dysplasia in the leukoplakia; therefore, its expression may decrease in SCC with higher grades. There were no significant correlations between MI and TI with tumor grade (p= 0.85). Matsumoto et al. [29] obtained the same results, although they studied esophagus cancer.
Ito et al. [22] found that P57 expression decreased in adenocarcinoma stage IV. Expression of this marker had a significant correlation with biologic invasion such as lymph node metastasis, invasion to capsule and lymphatic vessels, bigger size and higher proliferation rate, while there was no correlation with grade of tumor.
Liang et al. [30] found no correlation between P57 expression and tumor grade in human gastric cancer. These results were similar to ours. In contrast, Ito et al. [21] in their study on intrahepatic cholangiocellular carcinoma showed that P57 staining inversely correlated with carcinoma differentiation. This result was opposite to our results, which may be due to different location of tumors since SCC in different organs has different biological behaviors. Their study demonstrated that well and moderately differentiated tumors have a significant correlation with P57 labeling index. Akaishi et al. [23] showed that P57 labeling index was higher in high grades of astrocytoma, although it was not significant. 
